Trial intelligence / Profile preview

Collastat vs Floseal in elective OPCAB surgery

NCT04310150Phase 4Completed

Sponsor
Yonsei University
Start
Feb 2018
Primary completion
Mar 2020
Modality
Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of CollaStat in coronary artery disease (CAD), sponsored by Yonsei University. Started Feb 2018; status: completed.

02

Drugs

CollaStat
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT04310150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04310150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call